+2,358.4%
SNDK vs THC
+123.5%
+2,234.9%
-65.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.6% | -0.3% | -5.3% | -5.5% |
| 7D | +6.0% | +1.0% | +5.0% | +5.8% |
| 30D | -36.9% | +5.3% | -42.2% | -37.5% |
| 3M | -42.1% | +7.1% | -49.2% | -42.9% |
| 6M | -38.8% | +46.0% | -84.9% | -46.9% |
| YTD | +272.8% | +43.9% | +228.9% | +222.2% |
| 1Y | +263.3% | +45.4% | +217.9% | +213.1% |
| All | +2,358.4% | +123.5% | +2,234.9% | +1,575.8% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling